APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prothrombin Complex Concentrate(PCC)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Prothrombin Complex Concentrate(PCC) Market Outlook and Growth Opportunities 2026

30 December 2025198 pages

Choose your research edition.

Industry ResearchProthrombin Complex Concentrate(PCC) Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Prothrombin Complex Concentrate(PCC) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Prothrombin Complex Concentrate(PCC) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prothrombin Complex Concentrate(PCC) Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Prothrombin Complex Concentrate(PCC) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Prothrombin Complex Concentrate(PCC) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prothrombin Complex Concentrate(PCC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Prothrombin Complex Concentrate(PCC) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Prothrombin Complex Concentrate(PCC) market include CSL, WEIGUANG BIOLOGICAL, Taibang Biologic Group, SHANGHAI RAAS, Green Cross, Jiangxi Boya Bio-Pharmaceutical, HUALAN BIOLOGICAL ENGINEERING, Guangdong Shuanglin Biopharmaceutical and Beijing Tiantan Biological Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prothrombin Complex Concentrate(PCC) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prothrombin Complex Concentrate(PCC) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prothrombin Complex Concentrate(PCC) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prothrombin Complex Concentrate(PCC) market size, projected growth trends, production technologies, key applications, and end-use industries.

Prothrombin Complex Concentrate(PCC) Segment by Company

CSL

WEIGUANG BIOLOGICAL

Taibang Biologic Group

SHANGHAI RAAS

Green Cross

Jiangxi Boya Bio-Pharmaceutical

HUALAN BIOLOGICAL ENGINEERING

Guangdong Shuanglin Biopharmaceutical

Beijing Tiantan Biological Products

BOHUI

Biotest

Prothrombin Complex Concentrate(PCC) Segment by Type

1000IU

100IU

200IU

300IU

400IU

Prothrombin Complex Concentrate(PCC) Segment by Application

Hopistial

Clinic

Others

Prothrombin Complex Concentrate(PCC) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Prothrombin Complex Concentrate(PCC) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Prothrombin Complex Concentrate(PCC) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prothrombin Complex Concentrate(PCC) significant trends, drivers, influence factors in global and regions.

6. To analyze Prothrombin Complex Concentrate(PCC) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex Concentrate(PCC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex Concentrate(PCC) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex Concentrate(PCC).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prothrombin Complex Concentrate(PCC) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prothrombin Complex Concentrate(PCC) industry.

Chapter 3: Detailed analysis of Prothrombin Complex Concentrate(PCC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Prothrombin Complex Concentrate(PCC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Prothrombin Complex Concentrate(PCC) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Prothrombin Complex Concentrate(PCC) Industry Trends Table 2. Prothrombin Complex Concentrate(PCC) Industry Drivers Table 3. Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges Table 4. Prothrombin Complex Concentrate(PCC) Industry Restraints Table 5. Global Prothrombin Complex Concentrate(PCC) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Prothrombin Complex Concentrate(PCC) Revenue Share by Company (2021-2026) Table 7. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Company (2021-2026) Table 9. Global Prothrombin Complex Concentrate(PCC) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Prothrombin Complex Concentrate(PCC) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Prothrombin Complex Concentrate(PCC) Key Company Manufacturing Base & Headquarters Table 12. Global Prothrombin Complex Concentrate(PCC) Company, Product Type & Application Table 13. Global Prothrombin Complex Concentrate(PCC) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Prothrombin Complex Concentrate(PCC) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1000IU Table 18. Significant Companies of 100IU Table 19. Significant Companies of 200IU Table 20. Significant Companies of 300IU Table 21. Significant Companies of 400IU Table 22. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Type (2021-2026) Table 26. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Type (2027-2032) Table 27. Global Prothrombin Complex Concentrate(PCC) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Prothrombin Complex Concentrate(PCC) Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Prothrombin Complex Concentrate(PCC) Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Type (2021-2026) Table 31. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Hopistial Table 33. Significant Companies of Clinic Table 34. Significant Companies of Others Table 35. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Application (2021-2026) Table 39. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Application (2027-2032) Table 40. Global Prothrombin Complex Concentrate(PCC) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Prothrombin Complex Concentrate(PCC) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Prothrombin Complex Concentrate(PCC) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Application (2021-2026) Table 44. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Application (2027-2032) Table 45. Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2021-2026) & (K Units) Table 47. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2021-2026) Table 48. Global Prothrombin Complex Concentrate(PCC) Sales by Region (2027-2032) & (K Units) Table 49. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region (2027-2032) Table 50. Global Prothrombin Complex Concentrate(PCC) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Prothrombin Complex Concentrate(PCC) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Region (2021-2026) Table 53. Global Prothrombin Complex Concentrate(PCC) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Region (2027-2032) Table 55. Global Prothrombin Complex Concentrate(PCC) Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Prothrombin Complex Concentrate(PCC) Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Prothrombin Complex Concentrate(PCC) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Prothrombin Complex Concentrate(PCC) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2026) & (K Units) Table 60. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2021-2026) Table 61. Global Prothrombin Complex Concentrate(PCC) Sales by Country (2027-2032) & (K Units) Table 62. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Country (2027-2032) Table 63. Global Prothrombin Complex Concentrate(PCC) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Prothrombin Complex Concentrate(PCC) Sales Value Market Share by Country (2021-2026) Table 65. Global Prothrombin Complex Concentrate(PCC) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Prothrombin Complex Concentrate(PCC) Sales Value Market Share by Country (2027-2032) Table 67. CSL Company Information Table 68. CSL Business Overview Table 69. CSL Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. CSL Prothrombin Complex Concentrate(PCC) Product Portfolio Table 71. CSL Recent Development Table 72. WEIGUANG BIOLOGICAL Company Information Table 73. WEIGUANG BIOLOGICAL Business Overview Table 74. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio Table 76. WEIGUANG BIOLOGICAL Recent Development Table 77. Taibang Biologic Group Company Information Table 78. Taibang Biologic Group Business Overview Table 79. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio Table 81. Taibang Biologic Group Recent Development Table 82. SHANGHAI RAAS Company Information Table 83. SHANGHAI RAAS Business Overview Table 84. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio Table 86. SHANGHAI RAAS Recent Development Table 87. Green Cross Company Information Table 88. Green Cross Business Overview Table 89. Green Cross Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio Table 91. Green Cross Recent Development Table 92. Jiangxi Boya Bio-Pharmaceutical Company Information Table 93. Jiangxi Boya Bio-Pharmaceutical Business Overview Table 94. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio Table 96. Jiangxi Boya Bio-Pharmaceutical Recent Development Table 97. HUALAN BIOLOGICAL ENGINEERING Company Information Table 98. HUALAN BIOLOGICAL ENGINEERING Business Overview Table 99. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio Table 101. HUALAN BIOLOGICAL ENGINEERING Recent Development Table 102. Guangdong Shuanglin Biopharmaceutical Company Information Table 103. Guangdong Shuanglin Biopharmaceutical Business Overview Table 104. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio Table 106. Guangdong Shuanglin Biopharmaceutical Recent Development Table 107. Beijing Tiantan Biological Products Company Information Table 108. Beijing Tiantan Biological Products Business Overview Table 109. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio Table 111. Beijing Tiantan Biological Products Recent Development Table 112. BOHUI Company Information Table 113. BOHUI Business Overview Table 114. BOHUI Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio Table 116. BOHUI Recent Development Table 117. Biotest Company Information Table 118. Biotest Business Overview Table 119. Biotest Prothrombin Complex Concentrate(PCC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio Table 121. Biotest Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Prothrombin Complex Concentrate(PCC) Distributors List Table 125. Prothrombin Complex Concentrate(PCC) Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Prothrombin Complex Concentrate(PCC) Product Image Figure 2. Global Prothrombin Complex Concentrate(PCC) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Prothrombin Complex Concentrate(PCC) Sales (2021-2032) & (K Units) Figure 5. Global Prothrombin Complex Concentrate(PCC) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Prothrombin Complex Concentrate(PCC) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1000IU Image Figure 10. 100IU Image Figure 11. 200IU Image Figure 12. 300IU Image Figure 13. 400IU Image Figure 14. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Type (2021-2032) Figure 17. Global Prothrombin Complex Concentrate(PCC) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Prothrombin Complex Concentrate(PCC) Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Type (2021-2032) Figure 20. Hopistial Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Application (2021-2032) Figure 26. Global Prothrombin Complex Concentrate(PCC) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Prothrombin Complex Concentrate(PCC) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Application (2021-2032) Figure 29. Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Prothrombin Complex Concentrate(PCC) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Prothrombin Complex Concentrate(PCC) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Prothrombin Complex Concentrate(PCC) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Prothrombin Complex Concentrate(PCC) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Prothrombin Complex Concentrate(PCC) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Prothrombin Complex Concentrate(PCC) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Prothrombin Complex Concentrate(PCC) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • 1000IU
  • 100IU
  • 200IU
  • 300IU
  • 400IU
Applications
  • Hopistial
  • Clinic
  • Others
Companies covered
  • CSL
  • WEIGUANG BIOLOGICAL
  • Taibang Biologic Group
  • SHANGHAI RAAS
  • Green Cross
  • Jiangxi Boya Bio-Pharmaceutical
  • HUALAN BIOLOGICAL ENGINEERING
  • Guangdong Shuanglin Biopharmaceutical
  • Beijing Tiantan Biological Products
  • BOHUI
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032)
  4. 1.2.2 Global Prothrombin Complex Concentrate(PCC) Sales Volume (2021-2032)
  5. 1.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Prothrombin Complex Concentrate(PCC) Market Dynamics
  1. 2.1 Prothrombin Complex Concentrate(PCC) Industry Trends
  2. 2.2 Prothrombin Complex Concentrate(PCC) Industry Drivers
  3. 2.3 Prothrombin Complex Concentrate(PCC) Industry Opportunities and Challenges
  4. 2.4 Prothrombin Complex Concentrate(PCC) Industry Restraints
3 Prothrombin Complex Concentrate(PCC) Market by Company
  1. 3.1 Global Prothrombin Complex Concentrate(PCC) Company Revenue Ranking in 2025
  2. 3.2 Global Prothrombin Complex Concentrate(PCC) Revenue by Company (2021-2026)
  3. 3.3 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Company (2021-2026)
  4. 3.4 Global Prothrombin Complex Concentrate(PCC) Average Price by Company (2021-2026)
  5. 3.5 Global Prothrombin Complex Concentrate(PCC) Company Ranking (2024-2026)
  6. 3.6 Global Prothrombin Complex Concentrate(PCC) Company Manufacturing Base and Headquarters
  7. 3.7 Global Prothrombin Complex Concentrate(PCC) Company Product Type and Application
  8. 3.8 Global Prothrombin Complex Concentrate(PCC) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Prothrombin Complex Concentrate(PCC) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Prothrombin Complex Concentrate(PCC) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Prothrombin Complex Concentrate(PCC) Market by Type
  1. 4.1 Prothrombin Complex Concentrate(PCC) Type Introduction
  2. 4.1.1 1000IU
  3. 4.1.2 100IU
  4. 4.1.3 200IU
  5. 4.1.4 300IU
  6. 4.1.5 400IU
  7. 4.2 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type
  8. 4.2.1 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Prothrombin Complex Concentrate(PCC) Sales Value by Type
  12. 4.3.1 Global Prothrombin Complex Concentrate(PCC) Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Prothrombin Complex Concentrate(PCC) Sales Value by Type (2021-2032)
  14. 4.3.3 Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Type (2021-2032)
5 Prothrombin Complex Concentrate(PCC) Market by Application
  1. 5.1 Prothrombin Complex Concentrate(PCC) Application Introduction
  2. 5.1.1 Hopistial
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application
  6. 5.2.1 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prothrombin Complex Concentrate(PCC) Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Prothrombin Complex Concentrate(PCC) Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Prothrombin Complex Concentrate(PCC) Sales Value by Application
  10. 5.3.1 Global Prothrombin Complex Concentrate(PCC) Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prothrombin Complex Concentrate(PCC) Sales Value by Application (2021-2032)
  12. 5.3.3 Global Prothrombin Complex Concentrate(PCC) Sales Value Share by Application (2021-2032)
6 Prothrombin Complex Concentrate(PCC) Regional Sales and Value Analysis
  1. 6.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2021-2032)
  3. 6.2.1 Global Prothrombin Complex Concentrate(PCC) Sales by Region: 2021-2026
  4. 6.2.2 Global Prothrombin Complex Concentrate(PCC) Sales by Region (2027-2032)
  5. 6.3 Global Prothrombin Complex Concentrate(PCC) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Prothrombin Complex Concentrate(PCC) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Prothrombin Complex Concentrate(PCC) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Prothrombin Complex Concentrate(PCC) Sales Value by Region (2027-2032)
  9. 6.5 Global Prothrombin Complex Concentrate(PCC) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032)
  12. 6.6.2 North America Prothrombin Complex Concentrate(PCC) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032)
  15. 6.7.2 Europe Prothrombin Complex Concentrate(PCC) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Prothrombin Complex Concentrate(PCC) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032)
  21. 6.9.2 South America Prothrombin Complex Concentrate(PCC) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Prothrombin Complex Concentrate(PCC) Sales Value Share by Country, 2025 VS 2032
7 Prothrombin Complex Concentrate(PCC) Country-level Sales and Value Analysis
  1. 7.1 Global Prothrombin Complex Concentrate(PCC) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Prothrombin Complex Concentrate(PCC) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2032)
  4. 7.3.1 Global Prothrombin Complex Concentrate(PCC) Sales by Country (2021-2026)
  5. 7.3.2 Global Prothrombin Complex Concentrate(PCC) Sales by Country (2027-2032)
  6. 7.4 Global Prothrombin Complex Concentrate(PCC) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Prothrombin Complex Concentrate(PCC) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Prothrombin Complex Concentrate(PCC) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Prothrombin Complex Concentrate(PCC) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Prothrombin Complex Concentrate(PCC) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Prothrombin Complex Concentrate(PCC) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSL Prothrombin Complex Concentrate(PCC) Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 WEIGUANG BIOLOGICAL
  8. 8.2.1 WEIGUANG BIOLOGICAL Company Information
  9. 8.2.2 WEIGUANG BIOLOGICAL Business Overview
  10. 8.2.3 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 WEIGUANG BIOLOGICAL Prothrombin Complex Concentrate(PCC) Product Portfolio
  12. 8.2.5 WEIGUANG BIOLOGICAL Recent Developments
  13. 8.3 Taibang Biologic Group
  14. 8.3.1 Taibang Biologic Group Company Information
  15. 8.3.2 Taibang Biologic Group Business Overview
  16. 8.3.3 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Taibang Biologic Group Prothrombin Complex Concentrate(PCC) Product Portfolio
  18. 8.3.5 Taibang Biologic Group Recent Developments
  19. 8.4 SHANGHAI RAAS
  20. 8.4.1 SHANGHAI RAAS Company Information
  21. 8.4.2 SHANGHAI RAAS Business Overview
  22. 8.4.3 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SHANGHAI RAAS Prothrombin Complex Concentrate(PCC) Product Portfolio
  24. 8.4.5 SHANGHAI RAAS Recent Developments
  25. 8.5 Green Cross
  26. 8.5.1 Green Cross Company Information
  27. 8.5.2 Green Cross Business Overview
  28. 8.5.3 Green Cross Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Green Cross Prothrombin Complex Concentrate(PCC) Product Portfolio
  30. 8.5.5 Green Cross Recent Developments
  31. 8.6 Jiangxi Boya Bio-Pharmaceutical
  32. 8.6.1 Jiangxi Boya Bio-Pharmaceutical Company Information
  33. 8.6.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
  34. 8.6.3 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Boya Bio-Pharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
  36. 8.6.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
  37. 8.7 HUALAN BIOLOGICAL ENGINEERING
  38. 8.7.1 HUALAN BIOLOGICAL ENGINEERING Company Information
  39. 8.7.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
  40. 8.7.3 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 HUALAN BIOLOGICAL ENGINEERING Prothrombin Complex Concentrate(PCC) Product Portfolio
  42. 8.7.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
  43. 8.8 Guangdong Shuanglin Biopharmaceutical
  44. 8.8.1 Guangdong Shuanglin Biopharmaceutical Company Information
  45. 8.8.2 Guangdong Shuanglin Biopharmaceutical Business Overview
  46. 8.8.3 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Shuanglin Biopharmaceutical Prothrombin Complex Concentrate(PCC) Product Portfolio
  48. 8.8.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
  49. 8.9 Beijing Tiantan Biological Products
  50. 8.9.1 Beijing Tiantan Biological Products Company Information
  51. 8.9.2 Beijing Tiantan Biological Products Business Overview
  52. 8.9.3 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Tiantan Biological Products Prothrombin Complex Concentrate(PCC) Product Portfolio
  54. 8.9.5 Beijing Tiantan Biological Products Recent Developments
  55. 8.10 BOHUI
  56. 8.10.1 BOHUI Company Information
  57. 8.10.2 BOHUI Business Overview
  58. 8.10.3 BOHUI Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 BOHUI Prothrombin Complex Concentrate(PCC) Product Portfolio
  60. 8.10.5 BOHUI Recent Developments
  61. 8.11 Biotest
  62. 8.11.1 Biotest Company Information
  63. 8.11.2 Biotest Business Overview
  64. 8.11.3 Biotest Prothrombin Complex Concentrate(PCC) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Biotest Prothrombin Complex Concentrate(PCC) Product Portfolio
  66. 8.11.5 Biotest Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prothrombin Complex Concentrate(PCC) Value Chain Analysis
  2. 9.1.1 Prothrombin Complex Concentrate(PCC) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prothrombin Complex Concentrate(PCC) Sales Mode & Process
  6. 9.2 Prothrombin Complex Concentrate(PCC) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prothrombin Complex Concentrate(PCC) Distributors
  9. 9.2.3 Prothrombin Complex Concentrate(PCC) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst